Tobramycin - Cystic fibrosis
You are here : Home > Formulary Search > Tobramycin - Cystic fibrosis
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Documentation
NICE Technology Appraisal
PAD Profile
ChemicalSubstance :
Tobramycin
Indication :
Cystic fibrosis
Group Name :
Keywords :
NICE, antibiotic, antibacterial, aminoglycoside
Brand Names Include :
Tobi, Bramitob, Vantobra
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
1
Other Indications
Below are listed other indications that Tobramycin is used to treat.
- No records returned.
Other Drugs
Below are listed other drugs that are used to treat Cystic fibrosis.
Committee Recommendations (1)
01 Apr 13 -
Not Set
FOR NEW PATIENTS ONLY. Prescribing of Tobramycin will be considered RED on the Prescribing Advisory database. Historically amber for CF patients via nebulisation / inhalation (Not Tobi-Podhaler which has historically been RED). Funding now rests with NHS England for this treatment
FOR EXISTING PATIENTS: GPs should continue to prescribe these treatments. NHS England are looking to repatriate these patients in the future. The Medicines Management Team will be in contact with prescribers when they have more information
FOR EXISTING PATIENTS: GPs should continue to prescribe these treatments. NHS England are looking to repatriate these patients in the future. The Medicines Management Team will be in contact with prescribers when they have more information